From childhood to adulthood: Long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000)

Journal of Neuro-Oncology

Volumn 95, Issue 2, 2009, Pages 271-279

  Frange, P ^a   Alapetite, C ^a   Gaboriaud, G ^a   Bours, D ^a   Zucker, J M ^a   Zerah, M ^b,c   Brisse, H ^a   Chevignard, M ^d   Mosseri, V ^a   Bouffet, E ^e   Doz, Francois ^a,c  

^a INSTITUT CURIE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Rehabilitation Centre for Childhood Neurological Diseases   (France)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Children; Craniospinal radiotherapy; Long term sequelae; Medulloblastoma

Indexed keywords

ADOLESCENT; ADULT; ADULTHOOD; ALOPECIA; ARTICLE; CANCER SURVIVOR; CHILD; CHILDHOOD; COGNITION; CORTICOTROPIN DEFICIENCY; EARLY INTERVENTION; EMPLOYMENT STATUS; EYE EXAMINATION; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROLOGIC DISEASE; OBESITY; OPTIC NERVE ATROPHY; OTOTOXICITY; OUTCOME ASSESSMENT; PAIN; PRESCHOOL CHILD; QUALITY OF LIFE; RADIATION INJURY; SCHOOL CHILD; SELF REPORT; SOCIAL PSYCHOLOGY; SPINE INSTABILITY;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SPINAL CORD NEOPLASMS; SURVIVAL RATE; SURVIVORS; TREATMENT OUTCOME;

EID: 70350011946     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9927-z     Document Type: Article

References (45)

1. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7:813-820. doi: 10.1016/S1470-2045(06)70867-1
2. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202-4208. doi: 10.1200/JCO.2006.06.4980
3. Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24:5277-5282. doi: 10.1200/ JCO.2006.07.2884
4. Heikens J, Michiels EM, Behrendt H, Endert E, Bakker PJ, Fliers E (1998) Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 34:1592-1597. doi: 10.1016/ S0959-8049(98)00212-3
5. Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26:1112-1118. doi: 10.1200/JCO.2008.13.5293
6. Morris EB, Gajjar A, Okuma JO, Yasui Y, Wallace D, Kun LE, Merchant TE, Fouladi M, Broniscer A, Robison LL, Hudson MM (2007) Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 25:1532-1538. doi: 10.1200/JCO.2006.09.8194
7. Rauck AM, Green DM, Yasui Y, Mertens A, Robison LL (1999) Marriage in the survivors of childhood cancer: A preliminary description from the Childhood Cancer Survivor Study. Med Pediatr Oncol 33:60-63. doi: 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H
8. Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 23:2256-2263. doi: 10.1200/JCO.2005.01.158
9. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706-713. doi: 10.1200/JCO.2004.05.186
10. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, Sklar CA, Strong LC, Yasui Y, Zeltzer LK (2005) Long-Term Outcomes of Adult Survivors of Childhood Cancer. Results from the Childhood Cancer Survivor Study. Cancer 104:2557-2564. doi: 10.1002/cncr.21249
11. Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C (2005) Treatment of medulloblastoma with postoperative chemotherapy alone: An SFOP prospective trial in young children. Lancet Oncol 6:573-580. doi: 10.1016/ S1470-2045(05)70252-7
12. Gnekow AK (1995) Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. Med Pediatr Oncol 24:104-108. doi: 10.1002/mpo.2950240209
13. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351-1359
14. Carrie C, Alapetite C, Mere P, Aimard L, Pons A, Kolodie H, Seng S, Lagrange JL, Pontvert D, Pignon T et al (1992) Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol 24:77-81. doi: 10.1016/ 0167-8140(92)90282-Y
15. Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469
16. Bouffet E, Bernard JL, Frappaz D, Gentet JC, Roche H, Tron P, Carrie C, Raybaud C, Joannard A, Lapras C et al (1992) M4 protocol for cerebellar medulloblastoma: Supratentorial radiotherapy may not be avoided. Int J Radiat Oncol Biol Phys 24:79-85
17. Gentet JC, Bouffet E, Doz F, Tron P, Roche H, Thyss A, Plantaz D, Stephan JL, Mottolese C, Ponvert D et al (1995) Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: Results of the M7 French Cooperative Study. J Neurosurg 82:608-614
18. Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F (2005) Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 23:4726-4734. doi: 10.1200/ JCO.2005.00.760
19. Verlooy J, Mosseri V, Bracard S, Tubiana AL, Kalifa C, Pichon F, Frappaz D, Chastagner P, Pagnier A, Bertozzi AI, Gentet JC, Sariban E, Rialland X, Edan C, Bours D, Zerah M, Le Gales C, Alapetite C, Doz F (2006) Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. Eur J Cancer 42(17):3004-3014
20. Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J (1991) Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol 19:295-300. doi: 10.1002/mpo.2950190415
21. Feeny D, Furlong W, Boyle M, Torrance GW (1995) Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 7:490-502
22. Furlong WJ, Feeny DH, Torrance GW, Barr RD (2001) The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 33:375-384. doi: 10.3109/07853890109002092
23. Le Gales C, Costet N, Gentet JC, Kalifa C, Frappaz D, Edan C, Sariban E, Plantaz D, Doz F (1999) Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3. Int J Cancer Suppl 12:112-118. doi: 10.1002/(SICI)1097-0215(1999)83:12+ <112::AID-IJC20>3.0.CO;2-J
24. Le GC, Buron C, Costet N, Rosman S, Slama PR (2002) Development of a preference-weighted health status classification system in France: The Health Utilities Index 3. Health Care Manag Sci 5:41-51. doi: 10.1023/ A:1013201102918
25. Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1-55
26. Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, Bowers DC (2005) Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 72:245-253. doi: 10.1007/s11060-004-3009-z
27. Mulhern RK (1999) Correlation of the Health Utilities Index Mark 2 cognition scale and neuropsychological functioning among survivors of childhood medulloblastoma. Int J Cancer Suppl 12:91-94. doi: 10.1002/ (SICI)1097-0215(1999)83:12+<91::AID-IJC17>3.0.CO;2-O
28. Xu W, Janss A, Packer RJ, Phillips P, Goldwein J, Moshang T Jr (2004) Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. Neuro-oncology 6:113-118. doi: 10.1215/ S1152851703000462
29. Deheeger M, Bellisle F, Rolland-Cachera MF (2002) The French longitudinal study of growth and nutrition: Data in adolescent males and females. J Hum Nutr Diet 15:429-438. doi: 10.1046/ j.1365-277X.2002.00396.x
30. Heude B, Kettaneh A, de Lauzon Guillain B, Lommez A, Borys JM, Ducimetiere P, Charles MA (2006) Growth curves of anthropometric indices in a general population of French children and comparison with reference data. Eur J Clin Nutr 60:1430-1436. doi: 10.1038/sj.ejcn.1602474
31. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, Mertens A, Packer RJ, Robison LL, Sklar CA (2003) Final height and body mass index among adult survivors of childhood brain cancer: Childhood cancer survivor study. J Clin Endocrinol Metab 88:4731-4739. doi: 10.1210/ jc.2003-030784
32. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88:611-616. doi: 10.1210/jc.2002-021180
33. Bowers DC, Mulne AF, Reisch JS, Elterman RD, Munoz L, Booth T, Shapiro K, Doxey DL (2002) Nonperioperative strokes in children with central nervous system tumors. Cancer 94:1094-1101. doi: 10.1002/cncr.10353
34. Keene DL, Johnston DL, Grimard L, Michaud J, Vassilyadi M, Ventureyra E (2006) Vascular complications of cranial radiation. Childs Nerv Syst 22:547-555. doi: 10.1007/s00381-006-0097-4
35. Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL (2007) Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68:932-938. doi: 10.1212/ 01.wnl.0000257095.33125.48
36. Krishnamoorthy P, Freeman C, Bernstein ML, Lawrence S, Rodd C (2004) Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Arch Pediatr Adolesc Med 158:491-496. doi: 10.1001/archpedi.158.5.491
37. Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE (2004) Second neoplasms in pediatric patients with primary central nervous system tumors: The St. Jude Children's Research Hospital experience. Cancer 100:2246-2252. doi: 10.1002/cncr.20253
38. Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR (2007) Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors-on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239-4245. doi: 10.1200/JCO.2006.08.7684
39. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH (1999) Health-related quality of life in survivors of tumours of the central nervous system in childhood - a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 35:248-255. doi: 10.1016/ S0959-8049(98)00366-9
40. Glaser AW, Furlong W, Walker DA, Fielding K, Davies K, Feeny DH, Barr RD (1999) Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the UK. Eur J Cancer 35:256-261. doi: 10.1016/S0959-8049(98)00367-0
41. de Boer AG, Verbeek JH, van Dijk FJ (2006) Adult survivors of childhood cancer and unemployment. A metaanalysis. Cancer 107:1-11. doi: 10.1002/ cncr.21974
42. Hjern A, Lindblad F, Boman KK (2007) Disability in adult survivors of childhood cancer: A Swedish national cohort study. J Clin Oncol 25:5262-5266. doi: 10.1200/JCO.2007.12.3802
43. Howell S, Shalet S (1998) Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27:927-943. doi: 10.1016/ S0889-8529(05)70048-7
44. Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, Robison LL (2002) Predictors of smoking initiation and cessation among childhood cancer survivors: A report from the childhood cancer survivor study. J Clin Oncol 20:1608-1616. doi: 10.1200/JCO.20.6.1608
45. Emmons KM, Butterfield RM, Puleo E, Park ER, Mertens A, Gritz ER, Lahti M, Li FP (2003) Smoking among participants in the childhood cancer survivors cohort: The Partnership for Health Study. J Clin Oncol 21:189-196. doi: 10.1200/JCO.2003.06.130